Product Information
TIMOLOL 0.5% EYE DROP is a generic product labeled by Oceanside Pharmaceuticals, priced at $20.9770 per ML under NDC 68682004525. Its NADAC has been published 321 times since Apr 17, 2019.
FDA first approved this application on Jun 4, 2004. Its Orange Book therapeutic-equivalence code is AT2.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Oceanside PharmaceuticalsNDC
68682004525
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/17/2025
Active Ingredients
TIMOLOL MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021516FDA Approved
6/4/2004
TE Code
AT2
On Market Since
5/30/2018
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL 0.5% EYE DROP has been published 321 times since Apr 17, 2019, and over the history we have for it it has declined 32.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.9770 per ML |
|---|---|
| All-time high | $44.5800 (Jan 13, 2021) |
| All-time low | $20.9770 (Sep 17, 2025) |
| Median price | $30.8672 |
| Average price | $31.9614 |
| Largest weekly change | +47.1% (Oct 21, 2020) |
| Weeks tracked | 321 |
| Tracking since | Apr 17, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-10.7%
5Y
-43.8%
All
-32.0%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL 0.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.5% EYE DROP, manufactured by Oceanside Pharmaceuticals, is $20.9770 per ML (NDC 68682004525), effective Oct 1, 2025.
How has the price of TIMOLOL 0.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for TIMOLOL 0.5% EYE DROP has declined 32.0%. It has been tracked across 321 weekly CMS publications since Apr 17, 2019.
What are the highest and lowest recorded NADAC prices for TIMOLOL 0.5% EYE DROP?
Since Apr 17, 2019, the NADAC for TIMOLOL 0.5% EYE DROP has ranged from a low of $20.9770 (Sep 17, 2025) to a high of $44.5800 (Jan 13, 2021), with a median of $30.8672 per ML.
Are there cheaper alternatives to TIMOLOL 0.5% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL 0.5% EYE DROP, is $17.7216 per ML — about 16% below TIMOLOL 0.5% EYE DROP.
Who manufactures TIMOLOL 0.5% EYE DROP?
TIMOLOL 0.5% EYE DROP (NDC 68682004525) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.